Gene description
GO biological process
GMP biosynthetic process, oxidation-reduction process, response to cytokinin
GO cellular component
cytosol
GO molecular function
IMP dehydrogenase activity, metal ion binding
Metabolic pathway
Coexpression network
Differentially expressed condition
11 conditions
Series | Control | Treatment | Log2FC | Adj. P value |
---|---|---|---|---|
GSE17464 | Penta, control | Penta, Flg22 2 h | -2.01 | 8.57E-05 |
GSE17500 | Col, 35S:AFB1, control 0 h | Col, 35S:AFB1, PstDC3000 24 h | -1.78 | 1.78E-04 |
GSE17500 | Col, WT, control 0 h | Col, WT, PstDC3000 24 h | -2.50 | 6.26E-06 |
GSE17500 | Col, miR393, control 0 h | Col, miR393, PstDC3000 24 h | -1.96 | 7.21E-05 |
GSE18978 | Col, WT, control 24 h | Col, WT, PsmES4326 24 h | -4.02 | 3.75E-08 |
GSE21920 | Col, WT, mock | Col, WT, Pto HopZ1a 6 h | -1.87 | 2.38E-05 |
GSE45212 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 12 h | -2.60 | 1.12E-12 |
GSE45212 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 8 h | -2.37 | 6.23E-12 |
GSE45212 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 8 h | -1.81 | 2.15E-10 |
GSE45214 | Col, med16, PstDC3000 AvrRpt2 0 h | Col, med16, PstDC3000 AvrRpt2 4 h | -1.85 | 2.79E-13 |
GSE67100 | pDMR6:GFP GFP-negative, control 7 d | pDMR6:GFP GFP-positive, Hpa Noks1 7 d | -4.04 | 1.42E-02 |
Copyright © 2017 Ziding Zhang's Lab - China Agricultural University. All Rights Reserved.